Wednesday, March 14, 2012 10:37:45 PM
J Bling, you started out so well in your Post and then....... As I have said all along they did NOT getted booted from the Nasdaq as they "voluntarily" delisted and I believe that was done so in a good faith effort to aide them when filing again down the road for relisting. As for the pps falling from Dollars to sub penny... Alot of that had to do with fear once they delisted. Everyone bolted. This is one of the very few Co's I have seen in all my years that voluntarily walked away. They did so as they have an agenda and that is that ATRN is still viable and they knew they could get things back on track. That is precisely what they are doing at this point.
Let me pose this to you in a different Light to hopefully make a connection to ATRN. Lets say in life you, myself or others here on the Board have an issue here and there with finances etc..... Lets say we do the right thing and correct it as most would do. It may take a few months but ultimately we are back up and running again. Can the same not be said of ATRN? Lets give it a break and let ATRN work thru things. That is precisely why they delisted themselves to do just that.
Let me pose this to you in a different Light to hopefully make a connection to ATRN. Lets say in life you, myself or others here on the Board have an issue here and there with finances etc..... Lets say we do the right thing and correct it as most would do. It may take a few months but ultimately we are back up and running again. Can the same not be said of ATRN? Lets give it a break and let ATRN work thru things. That is precisely why they delisted themselves to do just that.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
